These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2498447)

  • 1. Super high estradiol response to gonadotropin stimulation in patients undergoing in vitro fertilization.
    Diamond MP; Buchholz T; Boyers SP; Lavy G; Shapiro BS; DeCherney AH
    J In Vitro Fert Embryo Transf; 1989 Apr; 6(2):81-4. PubMed ID: 2498447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of pure FSH alone or in combination for ovulation stimulation in in vitro fertilization.
    Acosta AA; Bernardus RE; Jones GE; Garcia J; Rosenwaks Z; Simonetti S; Veeck LL; Jones D
    Acta Eur Fertil; 1985; 16(2):81-99. PubMed ID: 3929523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization.
    Agrawal R; Conway GS; Engmann L; Bekir JS; Jacobs HS
    Gynecol Endocrinol; 1998 Feb; 12(1):9-15. PubMed ID: 9526704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular monitoring and outcome of in vitro fertilization in gonadotropin-releasing hormone-agonist-treated cycles.
    Forman RG; Robinson J; Egan D; Ross C; Gosden B; Barlow DH
    Fertil Steril; 1991 Mar; 55(3):567-73. PubMed ID: 1900482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal profiles in successful and unsuccessful implantation in IVF-ET after combined GnRH agonist/gonadotropin treatment for superovulation and hCG luteal support.
    Balasch J; Creus M; Fábregues F; Carmona F; Casamitjana R; Peñarrubia J; Rivera F; Vanrell JA
    Gynecol Endocrinol; 1995 Mar; 9(1):51-8. PubMed ID: 7793300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The day of initiation of human menopausal gonadotropin stimulation affects follicular growth in in vitro fertilization cycles.
    Dlugi AM; Laufer N; Decherney AH; Polan ML; Haseltine FP; Tarlatzis BC; Graebe RA; Barnea ER; Naftolin F
    J In Vitro Fert Embryo Transf; 1985 Mar; 2(1):33-40. PubMed ID: 3926922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered follicular development in clomiphene citrate versus human menopausal gonadotropin-stimulated cycles for in vitro fertilization.
    Dlugi AM; Laufer N; Botero-Ruiz W; DeCherney AH; Polan ML; Haseltine FP; Mezer HC; Behrman HR
    Fertil Steril; 1985 Jan; 43(1):40-7. PubMed ID: 3155509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of pituitary gonadotropins in follicular stimulation and oocyte maturation in the human.
    Jones GS; Garcia JE; Rosenwaks Z
    J Clin Endocrinol Metab; 1984 Jul; 59(1):178-80. PubMed ID: 6427270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of elevated early follicular-phase follicle stimulating hormone (FSH) levels: observations in unstimulated in vitro fertilization cycles.
    Lindheim SR; Sauer MV; Francis MM; Macaso TM; Lobo RA; Paulson RJ
    J Assist Reprod Genet; 1996 Jan; 13(1):49-52. PubMed ID: 8825167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship among serum levels of luteinizing hormone, estradiol, and progesterone during follicle stimulation and results of in vitro fertilization and embryo transfer (IVF-ET).
    Kagawa T; Yamano S; Nishida S; Murayama S; Aono T
    J Assist Reprod Genet; 1992 Apr; 9(2):106-12. PubMed ID: 1627924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very high serum estradiol levels are not detrimental to clinical outcome of in vitro fertilization.
    Chenette PE; Sauer MV; Paulson RJ
    Fertil Steril; 1990 Nov; 54(5):858-63. PubMed ID: 2121555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of highly purified FSH (metrodin-high purity) with pergonal for IVF superovulation.
    Bagratee JS; Lockwood G; López Bernal A; Barlow DH; Ledger WL
    J Assist Reprod Genet; 1998 Feb; 15(2):65-9. PubMed ID: 9513843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low estradiol responses in oocyte donors undergoing gonadotropin stimulation do not influence clinical outcomes.
    Palmerola KL; Rudick BJ; Lobo RA
    J Assist Reprod Genet; 2018 Sep; 35(9):1675-1682. PubMed ID: 29704227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
    Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
    Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonist-suppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles.
    Penzias AS; Shamma FN; Gutmann JN; Seifer DB; DeCherney AH; Lavy G
    J Assist Reprod Genet; 1992 Jun; 9(3):244-7. PubMed ID: 1525454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of oestradiol values in IVF-ET under a combined GnRH analogue--desensitization and simultaneous gonadotrophin stimulation for the outcome of pregnancies.
    Mettler L; Tavmergen EN
    Hum Reprod; 1989 Nov; 4(8 Suppl):59-64. PubMed ID: 2533218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian stimulation for in vitro fertilization using pure follicle-stimulating hormone with and without gonadotropin-releasing hormone agonist in high-responder patients.
    Edelstein MC; Brzyski RG; Jones GS; Oehninger S; Sieg SM; Muasher SJ
    J In Vitro Fert Embryo Transf; 1990 Jun; 7(3):172-6. PubMed ID: 2116488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormone profile and follicle development in ovarian stimulation treatment for in vitro fertilization. II. Prolactin, estradiol and progesterone profile].
    Sudik R; Fliess FR; Kunkel S
    Zentralbl Gynakol; 1989; 111(9):567-80. PubMed ID: 2500795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous luteinizing hormone (LH) surges are associated with more rapidly increasing estradiol (E2) and follicle stimulating hormone (FSH) in in vitro fertilization and embryo transfer.
    Kreiner D; Droesch K; Itskovitz J; Liu HC; Navot D; Rosenwaks Z
    J In Vitro Fert Embryo Transf; 1988 Oct; 5(5):265-7. PubMed ID: 3148022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.